Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Recruiting · NCT07332507 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, plasmablastic lymphoma | Recruiting | Phase 1 | 2026-10-01 | NCT07332507 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | United States | 189 |
| UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care | Irvine | United States | 95 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |